topic

Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors
Xingxing Hao, Louis D Falo III, Guo Chen, Jiying Zhang, Cara D Carey, Walter J Storkus, Louis D Falo Jr, Zhaoyang You

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001179; DOI: 10.1136/jitc-2020-001179
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu, Ruiqi Liu, Bojun Wang, Jie Lian, Yang Yao, Haoxiu Sun, Chunhui Zhang, Lin Fang, Xin Guan, Jiaqi Shi, Shuling Han, Fei Zhan, Shengnan Luo, Yuanfei Yao, Tongsen Zheng, Yanqiao Zhang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001895; DOI: 10.1136/jitc-2020-001895
Blockade of AIM2 inflammasome or α1-AR ameliorates IL-1β release and macrophage-mediated immunosuppression induced by CAR-T treatment
Dan Liu, Xiyue Xu, Yulian Dai, Xuan Zhao, Shunshun Bao, Wen Ma, Li Zha, Shuci Liu, Yuchen Liu, Junnian Zheng, Ming Shi

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001466; DOI: 10.1136/jitc-2020-001466
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts
Rachel A Woolaver, Xiaoguang Wang, Alexandra L Krinsky, Brittany C Waschke, Samantha M Y Chen, Vince Popolizio, Andrew G Nicklawsky, Dexiang Gao, Zhangguo Chen, Antonio Jimeno, Xiao-Jing Wang, Jing Hong Wang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001615; DOI: 10.1136/jitc-2020-001615
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
Martina Markovska, Francesco Marincola

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e002216; DOI: 10.1136/jitc-2020-002216
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report
Carolin Blumendeller, Julius Boehme, Maximilian Frick, Martin Schulze, Antje Rinckleb, Christina Kyzirakos, Simone Kayser, Maria Kopp, Sabine Kelkenberg, Natalia Pieper, Oliver Bartsch, Dirk Hadaschick, Florian Battke, Arnulf Stenzl, Saskia Biskup

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001406; DOI: 10.1136/jitc-2020-001406
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Razan Alzeibak, Tatiana A. Mishchenko, Natalia Y. Shilyagina, Irina V. Balalaeva, Maria V. Vedunova, Dmitri V. Krysko

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001926; DOI: 10.1136/jitc-2020-001926
Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
Fangwen Zou, Xuemei Wang, Isabella C Glitza Oliva, Jennifer L McQuade, Jennifer Wang, Hao Chi Zhang, John A Thompson, Anusha S Thomas, Yinghong Wang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e002058; DOI: 10.1136/jitc-2020-002058
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
Tamara A Sussman, Hong Li, Brian Hobbs, Pauline Funchain, Keith R McCrae, Alok A Khorana

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001719; DOI: 10.1136/jitc-2020-001719
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression
Marina Natoli, John Gallon, Haonan Lu, Ala Amgheib, David J Pinato, Francesco A Mauri, Teresa Marafioti, Ayse U Akarca, Ines Ullmo, Jacey Ip, Eric O Aboagye, Robert Brown, Anastasios Karadimitris, Sadaf Ghaem-Maghami

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001519; DOI: 10.1136/jitc-2020-001519

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages